Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-004907
Filing Date
2025-06-17
Accepted
2025-06-17 16:28:43
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3899
  Complete submission text file 0001562180-25-004907.txt   5387
Mailing Address C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Mendelsohn Michael (Reporting) CIK: 0001591109 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39634 | Film No.: 251053692

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)